Evidence map›Paper›PMID 33560244›Full record

Trial reportJMIR mHealth and uHealth2021

Efficiency of an mHealth App and Chest-Wearable Remote Exercise Monitoring Intervention in Patients With Type 2 Diabetes: A Prospective, Multicenter Randomized Controlled Trial.

Jing Li, Dong Wei, Shuyi Liu, Mingxia Li, Xi Chen, Li Chen, Yuelei Wu, Wen Zhou, Lingyun Ouyang, Cuixia Tan and 2 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JMIR mHealth and uHealth, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 10 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 10 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Are Wearables Effective in LMICs?Public health reviews · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Jing LiDepartment of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, China.ORCID 0000-0002-5381-4716
Dong WeiDepartment of Endocrinology, Chengdu Second People's Hospital, Chengdu, China.ORCID 0000-0003-3900-6138
Shuyi LiuDepartment of Endocrinology, Chengdu No 1 People's Hospital, Chengdu, China.ORCID 0000-0002-5364-9618
Mingxia LiDepartment of Endocrinology, Chengdu Branch in Tibet of Huaxi Hospital affiliated with Sichuan University, Chengdu, China.ORCID 0000-0003-3027-4443
Xi ChenRecovery Plus Clinic, Chengdu, China.ORCID 0000-0001-8714-6691
Li ChenRecovery Plus Clinic, Chengdu, China.ORCID 0000-0002-4306-6232
Yuelei WuDepartment of Endocrinology, Chengdu No 1 People's Hospital, Chengdu, China.ORCID 0000-0001-6217-299X
Wen ZhouRecovery Plus Clinic, Chengdu, China.ORCID 0000-0001-8519-2520
Lingyun OuyangDepartment of Endocrinology, Chengdu Second People's Hospital, Chengdu, China.ORCID 0000-0002-9881-7128
Cuixia TanDepartment of Endocrinology, Chengdu No 1 People's Hospital, Chengdu, China.ORCID 0000-0003-4288-9584
Hongdao MengSchool of Aging Studies, College of Behavioral and Community Sciences, University of South Florida, Tampa, FL, United States.ORCID 0000-0003-4551-9562
Nanwei TongDepartment of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, China.ORCID 0000-0002-5395-3660
Sichuan University · CNChengdu Second People's Hospital · CNUniversity of South Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExercise has been recommended as a cornerstone for diabetes management. Supervised exercise is more efficient than unsupervised exercise but is less convenient and accessible.

objectiveWe aimed to determine the efficiency of exercise using a fitness app and heart rate band to remotely monitor patients with type 2 diabetes in comparison with that of traditional exercise.

methodsPatients with type 2 diabetes without severe complications or comorbidities were recruited to participate in this multicenter randomized controlled trial and were allocated to either the intervention or control group (1:1 ratio). Participants in both groups were asked to engage in moderate to vigorous physical activity for at least 150 minutes per week; each participant was prescribed individualized exercises. Participants in the intervention group were asked to follow exercise videos on the app and to wear a chest band; heart rate, exercise duration, and exercise intensity were recorded by the app. Participants in the control group self-reported exercise intensity and duration. Cardiopulmonary endurance, body composition, blood glucose level, and insulin level were assessed before and after a 3-month exercise program.

resultsOf the 101 participants who were enrolled, the majority of them (85/101, 84.2%) completed the study. Both groups had similar baseline characteristics, with the exception that participants in the intervention group were slightly younger and less likely to have hypertension. Self-reported exercise duration was longer than app-recorded exercise duration (control: mean 214 minutes/week; intervention: mean 193 minutes/week); in addition, a higher proportion of participants in the control group (29/41, 71%) than in the intervention group (18/44, 41%) met the 150-minute target for moderate to vigorous physical activity. However, compared with the control group, the intervention group had a larger increase in cardiopulmonary endurance (mean difference -2.0 bpm [beats per minute] vs 1.0 bpm; P=.02) and a larger decrease in body fat percentage (mean difference -1.8% vs -0.8%; P=.01). There was no difference in hemoglobin A1c level reduction between the two groups, yet more participants in the intervention group stopped taking their antidiabetic drugs or had their dosages lowered by an endocrinologist, compared with those in the control group. There were no serious adverse events in either group.

conclusionsThis was the first randomized controlled trial in China, to our knowledge, to test the efficiency of exercise using a fitness app and heart rate band to remotely monitor prescribed exercise in patients with type 2 diabetes. The findings of our study suggest that exercise programs may be more efficient if participants are remotely monitored with an app and heart rate band than if participants are not monitored.

trial registrationChinese Clinical Trial Register ChiCTR1800015963; http://www.chictr.org.cn/showprojen.aspx?proj=27080.

Indexed as

Diabetes Mellitus, Type 2Mobile ApplicationsTelemedicineWearable Electronic DevicesChinaExerciseHumansProspective Studiesexercise monitoringfitness appheart rate bandmobile phonerandomized controlled trialtype 2 diabetes

Identifiers

PMID33560244
PMCPMC7902189
OpenAlexW3119573168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.